#SfN16 Preview: Immunotherapy for Neurodegenerative Disease

Targeting the pathological processes underlying neurodegenerative disease with effective therapies remains one of the greatest yet most important challenges facing neuroscientists today. Among other conditions, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic lateral sclerosis (Lou Gherig’s disease) and frontotemporal dementia ravage the cognitive and motor functions of their victims. While these diseases have unique genetic or environmental origins, they have one common neuropathological signature: aberrant accumulation of proteins – such as amyloid-β, tau, α-synuclein, huntingtin or SOD1. Because of this commonality, immunotherapy–by targeting the proteins implicated in disease onset and progression–is a promising candidate for treating a host of neurodegenerative diseases. On Wednesday, November 16 at the 2016 Society for Neuroscience conference, Dr. Eliezer Masliah, of the National Institutes of Health, will present the latest research on the use of…


Link to Full Article: #SfN16 Preview: Immunotherapy for Neurodegenerative Disease

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!